Amicus Therapeutics Announces Second Quarter 2009 Financial Results
... hydrochloride) for the treatment of Fabry disease In the second quarter of 2009, Amicus ... (afegostat tartrate) for the treatment of Gaucher disease A Phase 2 clinical trial of the Company's ... HCl) for the treatment of Pompe disease As previously reported, the Company ...TSH Testing Raises Awareness of Importance of Thyroid Health
... the link between nuclear reactors and thyroid disease near NYC was made at Croton on Hudson, during ... indicator of hypothyroidism, the most common disease of the thyroid. "There are no standard ... thyroid's activity and test for hypothyroidism, a disease that affects almost 30 million Americans. If this ...Shire plc: Core Portfolio of Products Delivers 20% Sales Growth
... approved and marketed treatment for Gaucher disease patients. This will allow physicians to treat Gaucher disease patients with velaglucerase alfa ahead of ... - Velaglucerase alfa for the treatment of Gaucher disease in the US and the EU in 2010; and - ...Winter Park Home to World's Foremost Producers of Large-Scale Decontamination Equipment
... with AeroClave, LLC, can help stop the spread of disease and infection. The revolutionary new system that ... with AeroClave, LLC, can help stop the spread of disease and infection. According to the Center for disease Control and the U.S. Department of Health and ...Oncothyreon announces presentation of long-term Stimuvax data at World Conference on Lung Cancer
... studied patients were alive without evidence of disease progression, of whom eight continued to receive ... years, respectively, and were without evidence of disease progression. Nine of the 10 living patients had ... 2.0 to 5.1 years of treatment as a result of disease progression and are deceased. Prolonged ...Oncolytics Biotech(R) Inc. Announces 2009 Second Quarter Results
... or 42% of evaluable patients experiencing stable disease (SD) for more than 16 weeks, including ... trial was well tolerated, and resulted in disease control for a majority of the patients. Of ... five patients had SD for 4-8 cycles, for a total disease control rate (CR (Complete ...Sunesis Reports Financial Results for the Second Quarter 2009
... dosing cohorts, 74 patients (52%) experienced disease control, defined as an objective response or stable disease for 12 weeks or more. The preliminary median ... in the U.S. during 2007. AML is generally a disease of older adults, and the median age of a patient ...UCSF researchers help crack parasite genome, identify drug leads
... to tackle schistosomiasis (bilharzia), a tropical disease that infects more than 200 million people ... affects global health." Caffrey said the disease places an estimated 600-700 million people at ... 6 weeks to reach adulthood and reproduce. For disease transmission, those eggs must be evacuated in ...Evidence for a New Genetic Link to Therapeutic Efficacy for Alzheimer's Disease
... in patients with mild-to-moderate Alzheimer's disease demonstrates an interaction between two genetic ... the 2009 International Conference on Alzheimer's disease (ICAD) sponsored by the Alzheimer's Association. ... to the physiological background of Alzheimer's disease were also performed. Previous analysis ...Novel gene found for dilated cardiomyopathy
... a novel gene responsible for heart muscle disease and chronic heart failure in some children and ... by which these inherited mutations cause disease in a subset of DCM patients." DCM is a condition ... mechanisms involved in the development of this disease and will enable better genetic testing and new ...New method may accelerate drug discovery for difficult diseases like Parkinson's
... of a well-established yeast model of Parkinson's disease that was created in the Lindquist lab. Parkinson's disease is a neurodegenerative disorder characterized by ... and current Parkinson's therapies only address disease symptoms. In the Lindquist yeast model, the ...Novel drug discovery tool could identify promising new therapies for Parkinson's disease
... levels of a protein implicated in Parkinson's disease by stimulating the cells to make very small ... Parkinson's disease, but theoretically for any disease where key aspects of the pathology can be ... J. Fox Foundation and the American Parkinson's disease Association. ...iZumi Bio and Pierian Merge to Form iPierian to Advance Cellular Reprogramming
... of the Gladstone Institute of Cardiovascular disease and professor at the University of California ... Our initial focus will be in neurodegenerative disease and longer term into metabolic and cardiovascular ... stem cell research and in the company's current disease area priorities. They include: ...New Drug Application for Exenatide Once Weekly Accepted for Review by FDA
... Diabetes is the fifth leading cause of death by disease in the U.S. and results in approximately $174 ... expenses.(iii) According to the Centers for disease Control and Prevention's National Health and ... problems digesting food or those who have severe disease of the stomach or kidney. When BYETTA is ...New Report Just Published: World Endoscopy Systems Market Report
... Laparoscopic Cholecystectomy / Gallstone disease II-26 Diaphragmatic Injury II-26 ... Splenic Aneurysms II-34 Treatment of Liver disease II-34 Nephrectomy II-34 Treatment of Polycystic Kidney disease II-35 Asymptomatic Pheochromocytoma II-35 ...VisEn Launches New Cat-K FAST(TM) Fluorescence Molecular Imaging Agent
... monitoring Cathepsin K activity associated with disease progression and therapeutic response in vivo . ... for precise measurement and monitoring of key disease biomarkers in vivo . VisEn's proprietary ... characterizing and quantifying ranges of disease biomarkers and therapeutic efficacy in vivo . ...It's Not Just the Sun: deCODE Discovers Sequence Variants Affecting Susceptibility to Skin Cancer
... of a sequence variant conferring risk of a disease that is dependent on the parent of origin. With ... with therapeutic applications in Alzheimer's disease and other conditions. deCODE is a global leader ... public health challenges from cardiovascular disease to cancer. Based upon these discoveries deCODE ...Bay Area Youth to Represent ALS Patients at Giants' and Angels' Baseball Games on July 4th
... (ALS, Lou Gehrig's disease) a neurodegenerative disease of which he suffers and for which there is no ... at both games will help to put a new face on this disease by providing a personal connection to ALS," said ... and ALS patients that are currently battling the disease at the start of the San Francisco Giants game. ...deCODE Discovers a Gene Linked to Risk of Kidney Stones and Osteoporosis
... with therapeutic applications in Alzheimer's disease and other conditions. deCODE is a global leader ... public health challenges from cardiovascular disease to cancer. Based upon these discoveries deCODE ... personal genome analysis service and new focused disease scans, integrating the genetic variants included ...deCODE Reinstated to Nasdaq Global Market
... with therapeutic applications in Alzheimer's disease and other conditions. deCODE is a global leader ... public health challenges from cardiovascular disease to cancer. Based upon these discoveries deCODE ... personal genome analysis service and new focused disease scans, integrating the genetic variants included ...Sanofi Pasteur Responds to Nation's Need for Hib Vaccine With Increased Supply
... increased supply, on July 1, the U.S. Centers for disease Control and Prevention (CDC) will reinstate its ... have passed, we have seen several cases of Hib disease primarily among unimmunized and partially ... constrained in the short term. About Hib disease Haemophilus influenzae type b, or Hib, is a ...Spherix Announces Termination of Arla License Agreement
... Type 2 diabetes mellitus (T2DM) is a disease that is characterized by elevated blood glucose ... medications are usually needed as the disease progresses. There are an estimated 23.6 million ... increase as an epidemic. Customarily considered a disease of adults, T2DM is increasingly being diagnosed ...